Allergan's Ulipristal, Dogged By Liver Concerns, Gets An FDA Rejection

US FDA issued a complete response letter for ulipristal acetate for the treatment of bleeding in women with uterine fibroids. The action wasn't unanticipated, but a disappointment nonetheless while Allergan tries to sell its women's health unit.